New MSU research shows that where you live can significantly affect your risk of developing and dying from lung cancer. People in rural or persistently poor communities face higher risks due to greater exposure and limited access to care.

On Sept. 16, Michigan State University received a national honor — the 2025 Golden Goose Award for the scientific success and global impact of cisplatin, the gold standard of cancer-fighting chemotherapy treatments.

An NIH-funded discovery at MSU may offer new hope against glioblastoma, the deadliest form of brain cancer. But cuts to federal research funding now threaten progress for families counting on breakthroughs like this.

As announced today, MSU will receive a 2025 Golden Goose Award for the scientific success and global impact of cisplatin. The Golden Goose Award is meant to highlight the practical value of curiosity-driven research.

Cancer fighters know that losing their hair is often part of the battle, but Michigan State University researchers have developed a shampoo-like gel that has been studied in animal models and could protect hair from falling out during chemotherapy treatment.

Julie Thomas-Beckett is a nurse practitioner who specializes in preventative and holistic care at MSU. Here, she discusses the importance of cervical cancer screenings and the latest information regarding cervical health in advance of Gynecologic Cancer Awareness Month in September. 

Cancer research in the U.S. is backed by a complex system of interdependent funding. Partners include academia, pharmaceutical companies, biotechnology start-ups, federal agencies and private foundations. These groups rely heavily on each other and, when one struggles, the entire system suffers.

People in Flint are concerned about elevated cancer rates, particularly multiple myeloma, and possible links to environmental exposures where they live, work, and play. For many in the community, a lack of high-quality reporting on cancer rates in the wake of the Flint water crisis can be highly distressing, worrisome, and frustrating.

Researchers from Henry Ford Health + Michigan State University Health Sciences have been awarded a $3 million grant from the National Institute of Dental and Craniofacial Research to study new treatments for patients who have head and neck cancer caused by the human papillomavirus, or HPV.

Four dedicated researchers from Michigan State University have received grants totaling more than $3 million from the American Cancer Society, or ACS, to find new ways to prevent, detect, treat and help patients survive colorectal, breast and cervical cancer.

Cancer research in the U.S. is backed by a complex system of interdependent funding. Here, Jeffrey MacKeigan explains how cancer research funding works and what happens if there are cuts to those budgets.

More than 250 researchers with Henry Ford Health + Michigan State University Health Sciences receive funding from federal agencies as well as other sources that supports their research focused on better diagnosis and treatment for cancer patients. They bring together diverse expertise across disciplines and, often, one advancement contributes to another.